Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Receivables - Net: 2024

Historic Receivables - Net for Stoke Therapeutics (STOK) over the last 1 years, with Dec 2024 value amounting to $1.7 million.

  • Stoke Therapeutics' Receivables - Net was N/A to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2024, which is N/A change from last year.
  • As of FY2024, Stoke Therapeutics' Receivables - Net stood at $1.7 million.
  • In the past 5 years, Stoke Therapeutics' Receivables - Net ranged from a high of $1.7 million in FY2024 and a low of $1.7 million during FY2024.
  • Moreover, its 1-year median value for Receivables - Net was $1.7 million (2024), whereas its average is $1.7 million.